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Soft-tissue sarcoma usually arises from the deep fascia or
skeletal muscles of the extremities. Primary breast sarcoma
not associated with other malignancies or previous irradiation
is extremely rare.1,2 Management remains controversial be-
cause of the rarity of the disease, and various authors hold
different opinions as to how breast sarcomas should be
managed. Furthermore, histological grading correlates poorly
with clinical behaviour.3 Advances in diagnostic methods,
such as immunohistochemistry and electron microscopy,
have enabled more accurate identification of the cellular ori-
gin of specific tumours.4 In this report, we present a case of
primary stromal tumour of the breast and review the relevant
literature.
Case report
A 36-year-old lady gave a history of a palpable mass in the right
breast for 3 years. She was nulliparous and had no family
history of breast cancer. There was no history of breast im-
plants or irradiation. On physical examination, the patient
was pale. She had a temperature of 38°C, blood pressure of
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110/70 mmHg and a pulse of 110 bpm. Breast examination
revealed a huge, fungating, irregular mass involving the entire
right breast. It was approximately 35 × 25 cm with areas of
haemorrhage and necrosis (Figure 1). The right axillary lymph
nodes were palpable. The contralateral breast was normal.
Haemoglobin was 5.3 g/dL. Chest roentgenography, bone
scintigraphy, abdominal ultrasound and computed tomogra-
phy of the chest, abdomen and brain were all normal. The
patient underwent right mastectomy with axillary lymph node
sampling .The wound was covered with a split-thickness skin
graft. The postoperative course was uneventful, and the graft
took completely. Microscopic examination showed a poorly
differentiated malignant tumour with large areas of necrosis
(Figure 2). Some areas showed entrapped atrophic breast
parenchyma. Normal and abnormal mitotic figures were seen
in the range of 8–9/high-power field. Immunohistochemistry
showed that all epithelial markers were negative except for
vimentin (Figure 3), and there was a weak reaction for smooth
muscle antigen; all other mesenchymal markers tested were
negative. Lymph nodes showed extensive tumour deposits
with large areas of necrosis. The tumour was diagnosed as
undifferentiated primary stromal sarcoma with extensive
lymph node metastasis.
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Figure 3. Strong vimentin staining.
Discussion
Breast sarcoma is a malignant neoplasm that arises from
mesenchymal tissue and is part of a wide spectrum of connec-
tive tissue tumours, accounting for less than 1% of malignant
breast lesions.5,6 The incidence, histological type and clinical
course of sarcomas of the breast are not well established. This
is due to the rarity of these tumours and a lack of definition in
various reports. Malignant phyllodes, lymphomas and even
carcinomas with pseudo-sarcomatous changes have been con-
sidered by some authors to be breast sarcomas.7 These neo-
plasms, therefore, pose a significant diagnostic and therapeu-
tic challenge.
Stromal sarcomas of the breast were first defined by
Berg et al in 1962.8 They excluded malignant phyllodes, lym-
phoma and angiosarcoma from their study. They described
25 cases of homogeneous tumours with fibrous, myxoid and
fatty patterns seen on light microscopy. The tumours were
named stromal sarcoma of the breast because they were
considered normal variants of mammary duct stroma. If
the morphological features of a specific type of sarcoma are
related to its cell of origin, e.g. “liposarcoma, fibrosarcoma” a
more meaningful classification for prognosis and therapy may
be proposed. The term “stromal sarcoma of the breast” should
be reserved for tumours lacking an epithelial component on
thorough histopathological sampling in which the cell of
origin cannot be determined.
Recently, genome-wide expression profiling has been used
to improve classification of soft-tissue sarcomas. Molecular
characterization of these tumours using a cDNA expression
microarray identified a group of genes associated with malig-
Figure 2. Poorly differentiated malignant tumour with frequent
normal and abnormal mitotic figures (8–9/high-power field). Some
areas show entrapped atrophic breast parenchyma.
Figure 1. Huge fungating irregular mass involving the entire right
breast with areas of haemorrhage and necrosis.
nant soft-tissue sarcoma such as fibrous histiocytoma and
liposarcoma. This technique may help in elucidating the cell
of origin of many of these tumours and may lead to recogni-
tion of new diagnostic and/or prognostic markers with thera-
peutic implications.9 The most commonly described breast
sarcomas are fibrosarcoma, liposarcoma and undifferentiated
high-grade sarcoma.2,4,10 Other sarcomatous lesions such as
leiomyosarcoma and sarcoma with bone and cartilage are
rare.6 The aetiology of breast sarcoma is unknown. It has
been suggested that a possible association exists between
implantation of a silicon prosthesis and breast sarcoma, but
this has not been proven. Angiosarcoma may be induced by
radiation.11
Breast sarcoma may spread by direct invasion and/or via
blood. Axillary lymph node involvement is very rare and is
usually associated with end-stage disease.12,13 In our patient,
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there was no distant metastasis, despite the advanced nature
of the primary tumour and extensive involvement of axillary
lymph nodes. Nodal disease is known to carry a poor prognosis,
tumour contour being an important prognostic factor. Tu-
mours with pushing margins seem to have a better progno-
sis than those with infiltrating borders; tumour size is of less
prognostic value. Lesions with a high mitotic rate have a poor
prognosis.14 Simple mastectomy with attainment of clear re-
section margins gives optimal results.15 Axillary lymphadenec-
tomy is important to ensure local clearance of the primary
tumour with the removal of clinically involved lymph nodes.16
Adjuvant radiotherapy may be indicated when the primary
tumour is bulky and/or when local clearance is not considered
satisfactory.17 The role of adjuvant chemotherapy has yet to be
defined.3 Breast sarcomas do not have hormonal receptors
and adjuvant hormonal therapy is, therefore, ineffective.18
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